✅ National monitoring across the UK
✅ Oncology focus, including solid tumor studies, Prostate, NSCLC, Leukemia, Breast, Glioblastoma & Hematological Malignancies
✅ Exposure to multiple protocols across Neuroscience, Cell/Gene Therapies, Respiratory, Cardiovascular, Infectious Disease, Nephrology, Endocrinology & Gastroenterology
✅ Risk-based monitoring model for smarter trial management
✅ 8+ on-site days per month